Ann: ResApp announces positive results of COVID-19 screening test, page-294

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 294 Last

Share
Profile

Follow
Sonny87

46 Posts.

137

23/03/22

11:22

Post #: 60363448
Share
Originally posted by ashtool: ↑

How is the app going to work for the very many (in some age brackets, the majority) who are asymptomatic and have no cough? It won't, thus people will still need RATs and PCRs.
How can an 80% clinical specificity (ie: 1/5 who are true 'positive' get a false-negative and re-enter the community) be reliable at all? I would be surprised if this underwhelming result even passes the TGA standard when it comes to it.
How does RAP substantiate its claim of "92% sensitivity for detecting COVID-19 with a new cough audio-based algorithm –exceeding the real-world measured sensitivity of rapid antigen testing" when the majority of new RATs being approved by the TGA have > 95% clinical sensitivity and > 98% clinical specificity?

Source: https://www.tga.gov.au/covid-19-rapid-antigen-self-tests-are-approved-australia

Table showing latest TGA approved RATs in Australia for home-use:

Clinical data or product:
This is just one example. Click on any of the "Very High sensitivity" TGA approved products, and all of them leave RAP's results for dead.

These are important questions to ask, given a CR likely approaching.

Expand

Hi Ashtool. Great to see you've heard the news. If you are genuinely interested in understanding the results and their real world application please watch the investor conference call. Their is a great explanation by Professor Catherine Bennett, Deakin’s Chair in Epidemiology within Deakin’s Institute for Health Transformation and member of Resapp's COVID-19 Scientific Advisory Board.
RAP Price at posting: 7.8¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

What's causing the cost-of-living crisis, and how to navigate it